top of page

Navigating the Onshore vs. Offshore Debate in Healthcare Supply Chains


Navigating the complex waters of healthcare supply chain management, industry experts have raised pivotal concerns about the reliance on offshore manufacturing and the pressing need to consider onshoring. The recent Power Supply Advisory Group meeting shed light on these issues, fostering a rich dialogue that weighs the potential impact and challenges associated with such a strategic pivot. The discussion underscored a shared understanding of the urgency to address the delicate interplay between supply chain robustness and the geopolitical uncertainties that could disrupt it. "How can we, in the United States, try to “turn the Titanic” the behemoth that it is, with overseas manufacturing to ensure a consistent supply," pondered Kelli McRory, encapsulating the monumental task ahead.


Country of Origin and Supply Chain Resilience: A Delicate Balancing Act


This metaphor of “turning the Titanic” captures the immense challenge of redirecting entrenched global supply chains toward a more localized model. The sentiment echoed throughout the discussion was one of caution coupled with a recognition of the urgent need for change. It's a question of strategic foresight—balancing the existing cost structures with the looming risks of over-dependence on offshore manufacturing. Matt Hoffmann reiterated these concerns about cost, stating, "You know, we talk about trying to bring more manufacturing onshore, but then there is the higher cost." His comments reflect the broader industry apprehension about the financial viability of such a shift, despite its potential benefits to supply chain security.


Cost Versus Security: The Healthcare Industry at a Crossroads


The debate over whether the increased costs of onshore manufacturing could be justified by the resulting supply security was central to the discussion. Will Gregory brought a pragmatic perspective to the table, suggesting that the focus might need to shift to diversification rather than onshoring. "Maybe everything has to be at least a dual source or multi-source," he said, proposing a strategy that could mitigate risk without necessitating a complete overhaul of current practices. Gregory's proposal aims to strike a balance between maintaining cost efficiency and ensuring a reliable supply chain—a sentiment that resonates with the fiscal responsibilities healthcare systems must uphold.


Strategic Sourcing and Control: Who Holds the Reins?


The meeting also delved into the role of strategic sourcing and who should drive these crucial decisions. "So, a main point of this conversation is who should drive this?" Justin Poulin queried, probing the extent of control hospitals truly have over their supply chains in partnership with GPOs and distributors. The strategic direction, it seems, is often dictated by these partnerships, leaving the healthcare providers with the illusion of control. This raises questions about the autonomy of healthcare systems in managing their supply chains and whether current sourcing strategies are adequate for the challenges ahead. The dialogue suggested a growing need for healthcare providers to assert more influence over their supply chain decisions, potentially redefining their relationships with GPOs and distributors.


The Future of Healthcare Supply Chains: A Collective Pledge for Change?


In contemplating the road ahead, Advisory Group members raised the idea of a collective commitment among health systems to reduce reliance on offshore sourcing. "Is it a pledge that needs to happen?" the group questioned, suggesting the need for a unified stance that could potentially drive the industry towards a more sustainable and secure supply chain model. The concept of a collective pledge underscores the recognition that no single institution can effect change in isolation; rather, it requires a concerted effort across the sector. The potential for a unified commitment could serve as a catalyst for broader industry transformation, promoting supply chain diversification and resilience as cornerstones of healthcare strategy.


Conclusion: The Onshore Question and the Path to Supply Chain Autonomy


The collective wisdom of the Advisory Group points to an industry at an inflection point. While the desire to mitigate risk and ensure supply chain resilience is palpable, the path forward is not without its challenges. It's a conversation that extends beyond the cost of goods to the very structure of healthcare supply chain management. As the industry considers these strategic shifts, it must do so with a clear understanding of the implications for cost, security, and the overall quality of patient care. The insights from the meeting serve not only as a reflection of the current state but also as a beacon for navigating the complex decisions that lie ahead. The commitment to onshoring or diversifying sources is not just about mitigating risk; it's about reimagining the supply chain to better serve the healthcare industry's mission to deliver exemplary patient care.

If you're interested in joining our Power Supply Advisory Group, we'd love to hear from you! Please send your inquiries and a copy of your resume to Justin Poulin at

50 views0 comments


Kommentare konnten nicht geladen werden
Es gab ein technisches Problem. Verbinde dich erneut oder aktualisiere die Seite.
bottom of page